Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized trial of TP-434 versus ertapenem in complicated intra-abdominal infection
2010-022548-19Phase 2Completed
- Sponsor
- Tetraphase Pharmaceuticals, Inc.
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of eravacycline in Intra-abdominal infection (IAI) (3 arms), sponsored by Tetraphase Pharmaceuticals, Inc. Primary endpoint: Clinical response at test-of-cure (TOC) visit. Started Feb 2011; status: completed.
02
Drugs
eravacycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on 2010-022548-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022548-19.